US Physical Therapy Analyst Ratings
US Physical Therapy Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/22/2023 | 14% | JP Morgan | → $108 | Initiates Coverage On | → Overweight |
| 09/19/2023 | — | CJS Securities | Upgrades | Market Perform → Market Outperform | |
| 08/14/2023 | 30.88% | Barrington Research | $116 → $124 | Maintains | Outperform |
| 06/30/2023 | 45.66% | B of A Securities | → $138 | Initiates Coverage On | → Buy |
| 05/05/2023 | 22.44% | Barrington Research | $110 → $116 | Maintains | Outperform |
| 02/24/2023 | 16.11% | Barrington Research | $107 → $110 | Maintains | Outperform |
| 12/14/2021 | 26.66% | CJS Securities | → $120 | Upgrades | Market Perform → Market Outperform |
| 05/07/2021 | 37.22% | Barrington Research | → $130 | Upgrades | Market Perform → Outperform |
| 05/03/2021 | 42.5% | Jefferies | $130 → $135 | Upgrades | Hold → Buy |
| 02/26/2021 | — | Barrington Research | Downgrades | Outperform → Market Perform | |
| 03/27/2020 | -15.56% | Sidoti & Co. | $128 → $80 | Maintains | Buy |
| 11/08/2019 | 37.22% | Barrington Research | → $130 | Upgrades | Market Perform → Outperform |
| 03/08/2019 | — | William Blair | Initiates Coverage On | → Outperform | |
| 11/02/2018 | 12.94% | Cantor Fitzgerald | $103 → $107 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/22/2023 | 百分之十四 | 摩根大通 | →$108 | 開始承保 | →超重 |
| 2023/09/19 | - | CJS證券 | 升級 | 市場表現優於→市場表現 | |
| 2023年08月14日 | 30.88% | 巴靈頓研究公司 | $116→$124 | 維護 | 跑贏大盤 |
| 2023/06/30 | 45.66% | B of A證券 | →$138 | 開始承保 | →購買 |
| 05/05/2023 | 22.44% | 巴靈頓研究公司 | $110→$116 | 維護 | 跑贏大盤 |
| 02/24/2023 | 16.11% | 巴靈頓研究公司 | $107→$110 | 維護 | 跑贏大盤 |
| 2021年12月14日 | 26.66% | CJS證券 | →$120 | 升級 | 市場表現優於→市場表現 |
| 05/07/2021 | 37.22% | 巴靈頓研究公司 | →$130 | 升級 | 市場表現優於→ |
| 05/03/2021 | 42.5% | 傑富瑞 | $130→$135 | 升級 | 持有→購買 |
| 02/26/2021 | - | 巴靈頓研究公司 | 評級下調 | 跑贏→市場表現 | |
| 03/27/2020 | -15.56% | 西多蒂公司 | $128→$80 | 維護 | 買 |
| 2019年8月11日 | 37.22% | 巴靈頓研究公司 | →$130 | 升級 | 市場表現優於→ |
| 2019年03月08日 | - | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
| 11/02/2018 | 12.94% | 康託·菲茨傑拉德 | $103→$107 | 維護 | 中性 |
What is the target price for US Physical Therapy (USPH)?
美國理療(USPH)的目標價格是多少？
The latest price target for US Physical Therapy (NYSE: USPH) was reported by JP Morgan on September 22, 2023. The analyst firm set a price target for $108.00 expecting USPH to rise to within 12 months (a possible 14.00% upside). 6 analyst firms have reported ratings in the last year.
摩根大通於2023年9月22日報道了美國物理療法(紐約證券交易所代碼：USPH)的最新目標價格。這家分析公司將目標價定為108.00美元，預計美元兌美元匯率將在12個月內上漲至14.00%。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for US Physical Therapy (USPH)?
分析師對美國理療(USPH)的最新評級是多少？
The latest analyst rating for US Physical Therapy (NYSE: USPH) was provided by JP Morgan, and US Physical Therapy initiated their overweight rating.
美國物理治療公司(紐約證券交易所代碼：USPH)的最新分析師評級是由摩根大通提供的，美國物理治療公司啟動了他們的增持評級。
When is the next analyst rating going to be posted or updated for US Physical Therapy (USPH)?
美國理療(USPH)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Physical Therapy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Physical Therapy was filed on September 22, 2023 so you should expect the next rating to be made available sometime around September 22, 2024.
分析師在進行了廣泛的研究後得出了股票評級，這些研究包括查閱公共財務報表，與美國理療公司的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。美國物理治療的上一次評級是在2023年9月22日提交的，所以你應該預計下一次評級將在2024年9月22日左右公佈。
Is the Analyst Rating US Physical Therapy (USPH) correct?
分析師對美國理療(USPH)的評級正確嗎？
While ratings are subjective and will change, the latest US Physical Therapy (USPH) rating was a initiated with a price target of $0.00 to $108.00. The current price US Physical Therapy (USPH) is trading at is $94.74, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但美國最新的理療評級是以0.00美元至108.00美元的目標價啟動的。目前美國理療(USPH)的交易價格為94.74美元，在分析師的預測範圍內。